Rapid evaluation of the COVID-19 pandemic response in PALLiative and end of life care: national delivery, workforce and symptom management (CovPall)CovPall-Connect: Evaluation of the COVID-19 pandemic response in palliative and end of life care: connecting to boost impact and data assets

King's College London0 个研究点目标入组 1,030 人开始时间: 2020年7月27日最近更新: 2024年8月19日

适应症

试验速览

2020 Preprint results in https://doi.org/10.1101/2020.10.29.20215996 non-peer-reviewed survey results on service innovation and practice change in preprint (added 19/03/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33556496/ survey results on challenges (added 19/03/2021) 2021 Funder report results in https://www.mariecurie.org.uk/globalassets/media/documents/policy/policy-publications/2021/better-end-of-life-research-report.pdf (added 24/11/2021) 2022 Results article in https://doi.org/10.1177/01410768221077366 (added 06/08/2024) 2021 Results article in https://doi.org/10.1177/02692163211000660 (added 06/08/2024) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36210447/ Charitably funded hospices and the challenges associated with the COVID-19 pandemic: a mixed-methods study (CovPall) (added 06/08/2024) 2022 Results article in https://doi.org/10.34172/ijhpm.2021.128 Prohibit, Protect, or Adapt? The Changing Role of Volunteers in Palliative and Hospice Care Services During the COVID-19 Pandemic. A Multinational Survey (Covpall) (added 06/08/2024) 2022 Results article in https://doi.org/10.1136/spcare-2022-003799 Symptom management in people dying with COVID-19: multinational observational study (added 06/08/2024)

•WP1: Clinical leads of palliative and hospice care services including: palliative care teams in acute hospitals, in-patient hospices/palliative care wards and palliative care community services providing care in peoples own homes and supporting care homes, usually for adults and children.
•WP2: Consecutive patients supported by the participating palliative care services in WP1 (including remote consultation), with clinically diagnosed and/or test confirmed COVID-19 diagnosis. This will include patients with and without pre-existing progressive conditions.

发起方